KYLE SMITH: Open Payments
NPI 1174130215 · DUBLIN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,756 in 81 payments from 13 companies in 2025. Trend: 2023 $599 · 2024 $1,221 · 2025 $1,756
Food & beverage: $1,756
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 19 | $323 |
| ABBVIE INC. | 23 | $321 |
| Boston Scientific Corporation | 15 | $312 |
| BIOTRONIK NRO, Inc. | 4 | $311 |
| VERTEX PHARMACEUTICALS INCORPORATED | 5 | $137 |
| Medtronic, Inc. | 1 | $82 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $74 |
| IBSA Pharma Inc. | 3 | $58 |
| Lundbeck LLC | 2 | $45 |
| PFIZER INC. | 2 | $34 |
Products named: Prospera, Belbuca, UBRELVY, General - Pain Management, General - Therapies, JOURNAVX, XTAMPZA, QULIPTA.
Industry payments across OH — which companies pay providers there.
